drugset / Trial / NCT03676296

Effect of Puerarin on Heart Health in Men

NCT03676296

RandomizedCrossoverDouble-blindPrevention

Summary

This study aims to assess the effect of puerarin supplementation on cardiovascular disease risk factors in men.

Timeline

Start
2018-09-05
Primary completion
2021-04-17
Completion
2021-04-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Puerarin Small molecule 90.2 mg Oral

Indications

No indication recorded.